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Letter to the Editor
CHLORPROMAZINE AND FALSELY ELEVATED PARTIAL THROMBOPLASTI N TIME
Dea r Editor:
The int ro duct ion of chlorpromazine in 1952 revolution ized the trea tmen t of psych ia tri c
disorders . By 1954 chlorpro maz ine had been linked to pot ent ial agra nulocystosis ( I) . Over the
last 37 years th e risk to ben efit ratio of th e drug has been scru tinized . C hlorpromazine st ill
remains th e gold standa rd by which othe r an t ipsychot ics must be judged .
W e rep ort th e case of a 58 year old ma le with Bipolar Affecti ve Disorder a nd Alcohol -
induced Dem entia who pr esented to th e m edi cal service with ches t pa in. Following eva lua tion
of th e patient's symptoms a nd risk factors it wa s elec te d to perform ca rd iac cat heri zat ion.
Prior to th e ca the riza t ion a pr otime and partial thromboplastin tim e wer e perform ed . The PT
wa s norm al at 11.2 seconds; how ever th e PTT was markedl y eleva ted at 5 1.5 second s.
Additiona l laboratory work including CBC a nd num eri cal platelet coun t was unrem arkable.
H ema tology Service was cons ulte d to eva lua te th e eleva ted PTT. They recommended
mix ing stud ies whi ch were com pa t ible with a coagu la t ion inhibitor. A Ru ssel's Viper Venom
T est wa s positive for a Lupus Antibody. The rem ainder of th e hem at ology workup was negative
a nd included RPR , ANA, ANA Antibody, and Rh eumatoid Fact or.
Psychiatric consu ltat ion was requested to det ermine if th e patient 's psychot rop ic med ica-
t ion was effec ting th e coa gula tion studies. The patient was on chlor pro mazi ne, lithium
ca rbona te a nd clonazep am. Hi s chlorpro mazine was dis continued and a n equiva lent dose of
ha lperidol was begun. His p'IT correct ed within on e week . Rep eat P'T'F's obta ine d at 2,4, and 6
months were no rm a l and no further abnorm ality was not ed.
The lupus a nt ibody is an IgM, or IgG immunoglobulin that pr oduces a prol on ged PTT by
binding to th e phospholipid used in th e in vitro I"T'l' assay . This labora tory ar t ifact does not
cause a clinica l bleeding dis order. The lupus a nt icoagu la nt is seen in 5- 10 percent of pat ien ts
with Syst emic Lupus Erythmatosus, but can be see n in pat ient s on ph en othiazines as with our
patient. (2)
Lupus like syndromes have been induced by ph en ytoin , hydral azin e, procain a mide and
isoniazid . The ph enothiazines, th ioxanthen es , butyrophenones a nd lithium have also been
report ed to induce ANA in some patients with ch ro n ic use. (3,4)
Zarrabi, in 1979 dem on strated th at most long te r m patients on ch lor pro mazine developed
immunologi c abnorm a liti es of significant IgM and prolongation of PTT. Fift y per cen t of th ese
patients also deve lop ed sp leenomegaly. (5)
Our purpose in wr iting this letter is to cau t ion other clinician s th at chlorpromazine can
often produce an artifactual elevation in th e PTT whi ch is secondary to a circula t ing Lupus
Ant ibody.
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The opinions in this paper a re so le ly th ose of th e aut hors a nd sho uld not be
cons t rued as represent ative of th e U niversity of Californ ia a t Davis or th e Dep art-
ment of Vet erans Affairs.
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